ASSESSMENT OF CARDIOVASCULAR RISK IN CASES OF HYPOTHYROIDISM: A HOSPITAL-BASED OBSERVATIONAL STUDY

Background: Hypothyroidism is among the most prevalent endocrine diseases, associated with metabolic and cardiovascular alterations including dyslipidemia, endothelial dysfunction, hypertension, and insulin resistance. Subclinical hypothyroidism (SCH), although often asymptomatic, has significant effects on cardiovascular health. Early identification of these cardiovascular risks is vital for the prevention of adverse cardiac events. Aim and Objectives: This study aimed to assess cardiovascular risk in patients with hypothyroidism by evaluating lipid profiles, thyroid function, blood pressure, cardiac status, and cardiovascular risk. Methodology: A hospital-based observational study was conducted on 60 adult patients diagnosed with hypothyroidism. Patients underwent detailed clinical evaluation, thyroid function tests, autoimmune thyroid markers (anti-TPO and anti-Tg), lipid profile assessment, inflammatory markers (CRP), blood pressure measurement, electrocardiography (ECG), echocardiography, and thyroid ultrasonography. Cardiovascular risk was estimated using the Framingham Risk Score.